source
- AI and data sharing essential for safer cell and gene therapies, says industry leaderThe author argues that keeping data secret in cell and gene therapy harms patients, and that a commitment to transparency and artificial intelligence is needed to make these treatments safer and mo…
- Regeneron ends eye disease study due to antibody's safety profileThe discontinuation of the uveitis study adds to Regeneron’s series of clinical setbacks, including the Phase 3 failures of the Dupixent follow-up itepekimab and an investigational combo regimen fo…BioSpace · 59m ago↗ source
- AstraZeneca reports positive late-stage results for Tagrisso-Orpathys combo and Enhertu in lung cancer